VantAI Expands Scientific Advisory Board with Leaders in Protein Design and Generative AI
VantAI, a company focused on generative AI-enabled drug discovery, today announced the appointments of Dr. Ian Churcher and Dr. Bradley Pentelute to its Scientific Advisory Board (SAB).